CRO Services
As your Contract Research Organization, OXON helps plan and implement the generation of Real-World evidence for safety, market access/HEOR and drug development.
KNOW MORELate-phase studies
We help pharmaceutical, biotech and medical device companies to cost-effectively meet the requirements of late-phase clinical studies for better outcomes or greater value.
KNOW MORETherapeutic Areas
OXON offers proven experience and a large portfolio of studies in all major therapy areas, including orphan conditions, pregnancy, and risk minimization.
KNOW MOREReal World Evidence and Late-Phase Research
OXON has been selected as a preferred provider by several big pharma companies.
With strong links to EMA and world-renowned academics and institutions in Europe and Asia for studies and teaching, OXON offers proven experience and a large portfolio of studies in all major therapeutic areas.
OXON conducts:
• Primary data studies: prospective, registries, retrospective chart review, cross-sectional, surveys and pragmatic trials
• Secondary data studies: electronic records and registries
• Hybrid studies, including external controls for orphan medicines
• Synthesis research: systematic review and aggregate and IPD meta-analysis and landscaping
• Data analysis, modelling and simulation
We strive our best to support our clients in conducting cost-efficient observational studies worldwide
We pulled together
professionals and resources to serve you better
READ MORELet us help design and conduct your optimal PASS or Outcomes observational study
OXON IS YOUR OBSERVATIONAL STUDIES SERVICE PROVIDER
OXON epidemiologists, statisticians, clinicians and project managers (ex-big pharma, ex-EMA), supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene & Tropical Medicine (´Pocock Stopping Rule´, sat on many data monitoring committees, extensive experience with EMA and FDA, classic textbook ´Clinical Trials´, >600 papers (100+ NEJM/Lancets)
REQUEST A MEETINGNewsroom
Read about us, our latest news and events
OXON’s FREE LIVE ONLINE REAL WORLD MASTERCLASS SERIES 2022-2023
FREE LIVE REAL WORLD MASTERCLASS SERIES 2022-2023 ‘How to ensure success and avoid pitfalls in Real World studies by Understanding Healthcare in Europe and Asia’ Dates: Monthly starting in February[…]
Read more
OXON at ICPE21 All Access Virtual Conference on 23-25 August, 2021
OXON is delighted to be supporting ICPE again this year with a virtual exhibition booth from which we will be happy to speak with you about our specialisation in data collection, secondary data and hybrid real world studies, pragmatic trials and meta-analyses to help plan, design and implement RWE for safety, market access and drug development.
Read more
Lancet study shows cholesterol in middle-age ‘linked to Alzheimer’s more than 10 years later’
The study, published in Lancet Healthy Longevity, suggests that high levels of cholesterol in middle-age are associated with an increased risk of developing dementia and Alzheimer’s disease. The retrospective cohort[…]
Read moreWe are a partner centre of the ENCePP scientific network, which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the EU PAS Register, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies
